Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial

R. Dummer; D. Schadendorf; A. Hauschild; M. Santinami; V. G. Atkinson; M. Mandala; V. Chiarion Sileni; J. Larkin; M. S. Nyakas; C. Dutriaux; A. Haydon; L. Mortier; C. Robert; J. Schachter; X. Feng; E. de Jong; B. Mookerjee; R. Kefford; J. M. Kirkwood; G. V. Long

doi:10.1093/annonc/mdy289.006

Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial

R. Dummer, D. Schadendorf, A. Hauschild, M. Santinami, V. G. Atkinson, M. Mandala, V. Chiarion Sileni, J. Larkin, M. S. Nyakas, C. Dutriaux, A. Haydon, L. Mortier, C. Robert, J. Schachter, X. Feng, E. de Jong, B. Mookerjee, R. Kefford, J. M. Kirkwood, G. V. Long

Faculty of Medicine, Health and Human Sciences

Research output: Contribution to journal › Article › peer-review

66 Citations (Scopus)

Original language	English
Article number	1250P
Pages (from-to)	viii445
Number of pages	1
Journal	Annals of Oncology
Volume	29
Issue number	Supplement 8
DOIs	https://doi.org/10.1093/annonc/mdy289.006
Publication status	Published - 1 Oct 2018
Event	43rd European Society for Medical Oncology Congress (ESMO 2018) - Munich, Germany Duration: 19 Oct 2018 → 23 Oct 2018

Access to Document

10.1093/annonc/mdy289.006

Cite this

Dummer, R., Schadendorf, D., Hauschild, A., Santinami, M., Atkinson, V. G., Mandala, M., Chiarion Sileni, V., Larkin, J., Nyakas, M. S., Dutriaux, C., Haydon, A., Mortier, L., Robert, C., Schachter, J., Feng, X., de Jong, E., Mookerjee, B., Kefford, R., Kirkwood, J. M., & Long, G. V. (2018). Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial. Annals of Oncology, 29(Supplement 8), viii445. Article 1250P. https://doi.org/10.1093/annonc/mdy289.006

@article{bb4f403db65349c8a077c05ae2e34ec9,

title = "Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial",

author = "R. Dummer and D. Schadendorf and A. Hauschild and M. Santinami and Atkinson, \{V. G.\} and M. Mandala and \{Chiarion Sileni\}, V. and J. Larkin and Nyakas, \{M. S.\} and C. Dutriaux and A. Haydon and L. Mortier and C. Robert and J. Schachter and X. Feng and \{de Jong\}, E. and B. Mookerjee and R. Kefford and Kirkwood, \{J. M.\} and Long, \{G. V.\}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy289.006",

language = "English",

volume = "29",

pages = "viii445",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Supplement 8",

note = "43rd European Society for Medical Oncology Congress (ESMO 2018) ; Conference date: 19-10-2018 Through 23-10-2018",

}

Dummer, R, Schadendorf, D, Hauschild, A, Santinami, M, Atkinson, VG, Mandala, M, Chiarion Sileni, V, Larkin, J, Nyakas, MS, Dutriaux, C, Haydon, A, Mortier, L, Robert, C, Schachter, J, Feng, X, de Jong, E, Mookerjee, B, Kefford, R, Kirkwood, JM & Long, GV 2018, 'Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial', Annals of Oncology, vol. 29, no. Supplement 8, 1250P, pp. viii445. https://doi.org/10.1093/annonc/mdy289.006

TY - JOUR

T1 - Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial

AU - Dummer, R.

AU - Schadendorf, D.

AU - Hauschild, A.

AU - Santinami, M.

AU - Atkinson, V. G.

AU - Mandala, M.

AU - Chiarion Sileni, V.

AU - Larkin, J.

AU - Nyakas, M. S.

AU - Dutriaux, C.

AU - Haydon, A.

AU - Mortier, L.

AU - Robert, C.

AU - Schachter, J.

AU - Feng, X.

AU - de Jong, E.

AU - Mookerjee, B.

AU - Kefford, R.

AU - Kirkwood, J. M.

AU - Long, G. V.

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://www.scopus.com/pages/publications/85041732145

U2 - 10.1093/annonc/mdy289.006

DO - 10.1093/annonc/mdy289.006

M3 - Article

C2 - 32137133

SN - 0923-7534

VL - 29

SP - viii445

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 8

M1 - 1250P

T2 - 43rd European Society for Medical Oncology Congress (ESMO 2018)

Y2 - 19 October 2018 through 23 October 2018

ER -

Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial

Access to Document

Other files and links

Cite this